nodes	percent_of_prediction	percent_of_DWPC	metapath
Lincomycin—Local reaction—Doxorubicin—kidney cancer	0.00394	0.00394	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Erlotinib—kidney cancer	0.00393	0.00393	CcSEcCtD
Lincomycin—Liver function test abnormal—Dactinomycin—kidney cancer	0.00389	0.00389	CcSEcCtD
Lincomycin—Vesiculobullous rash—Doxorubicin—kidney cancer	0.00389	0.00389	CcSEcCtD
Lincomycin—Stomatitis—Erlotinib—kidney cancer	0.00386	0.00386	CcSEcCtD
Lincomycin—Leukopenia—Temsirolimus—kidney cancer	0.00386	0.00386	CcSEcCtD
Lincomycin—Proteinuria—Capecitabine—kidney cancer	0.00385	0.00385	CcSEcCtD
Lincomycin—Agranulocytosis—Vinblastine—kidney cancer	0.00385	0.00385	CcSEcCtD
Lincomycin—Abdominal discomfort—Sorafenib—kidney cancer	0.00383	0.00383	CcSEcCtD
Lincomycin—Protein urine present—Capecitabine—kidney cancer	0.00379	0.00379	CcSEcCtD
Lincomycin—Oesophagitis—Paclitaxel—kidney cancer	0.00376	0.00376	CcSEcCtD
Lincomycin—Neutropenia—Sorafenib—kidney cancer	0.00374	0.00374	CcSEcCtD
Lincomycin—Dermatitis bullous—Gemcitabine—kidney cancer	0.00374	0.00374	CcSEcCtD
Lincomycin—Abdominal discomfort—Sunitinib—kidney cancer	0.00369	0.00369	CcSEcCtD
Lincomycin—Pancytopenia—Sunitinib—kidney cancer	0.00365	0.00365	CcSEcCtD
Lincomycin—Leukopenia—Pazopanib—kidney cancer	0.00364	0.00364	CcSEcCtD
Lincomycin—Neutropenia—Sunitinib—kidney cancer	0.0036	0.0036	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Sorafenib—kidney cancer	0.00353	0.00353	CcSEcCtD
Lincomycin—Anaphylactic shock—Temsirolimus—kidney cancer	0.00352	0.00352	CcSEcCtD
Lincomycin—Jaundice—Sorafenib—kidney cancer	0.00347	0.00347	CcSEcCtD
Lincomycin—Stomatitis—Sorafenib—kidney cancer	0.00347	0.00347	CcSEcCtD
Lincomycin—Phlebitis—Paclitaxel—kidney cancer	0.00347	0.00347	CcSEcCtD
Lincomycin—Pancytopenia—Dactinomycin—kidney cancer	0.00346	0.00346	CcSEcCtD
Lincomycin—Thrombophlebitis—Paclitaxel—kidney cancer	0.00345	0.00345	CcSEcCtD
Lincomycin—Neutropenia—Dactinomycin—kidney cancer	0.00341	0.00341	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Sunitinib—kidney cancer	0.0034	0.0034	CcSEcCtD
Lincomycin—Erythema multiforme—Erlotinib—kidney cancer	0.00336	0.00336	CcSEcCtD
Lincomycin—Stomatitis—Sunitinib—kidney cancer	0.00334	0.00334	CcSEcCtD
Lincomycin—Liver function test abnormal—Gemcitabine—kidney cancer	0.0033	0.0033	CcSEcCtD
Lincomycin—Shock—Pazopanib—kidney cancer	0.00326	0.00326	CcSEcCtD
Lincomycin—Colitis—Capecitabine—kidney cancer	0.00325	0.00325	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Dactinomycin—kidney cancer	0.00322	0.00322	CcSEcCtD
Lincomycin—Stomatitis—Dactinomycin—kidney cancer	0.00317	0.00317	CcSEcCtD
Lincomycin—Pancytopenia—Vincristine—kidney cancer	0.00309	0.00309	CcSEcCtD
Lincomycin—Oesophagitis—Capecitabine—kidney cancer	0.00309	0.00309	CcSEcCtD
Lincomycin—Neutropenia—Vincristine—kidney cancer	0.00304	0.00304	CcSEcCtD
Lincomycin—Agranulocytosis—Dactinomycin—kidney cancer	0.00303	0.00303	CcSEcCtD
Lincomycin—Erythema multiforme—Sorafenib—kidney cancer	0.00303	0.00303	CcSEcCtD
Lincomycin—Pain—Temsirolimus—kidney cancer	0.00301	0.00301	CcSEcCtD
Lincomycin—Tinnitus—Sorafenib—kidney cancer	0.00298	0.00298	CcSEcCtD
Lincomycin—Angioedema—Everolimus—kidney cancer	0.00293	0.00293	CcSEcCtD
Lincomycin—Pancytopenia—Gemcitabine—kidney cancer	0.00293	0.00293	CcSEcCtD
Lincomycin—Erythema multiforme—Sunitinib—kidney cancer	0.00291	0.00291	CcSEcCtD
Lincomycin—Vertigo—Vinblastine—kidney cancer	0.00289	0.00289	CcSEcCtD
Lincomycin—Neutropenia—Gemcitabine—kidney cancer	0.00289	0.00289	CcSEcCtD
Lincomycin—Leukopenia—Vinblastine—kidney cancer	0.00288	0.00288	CcSEcCtD
Lincomycin—Leukopenia—Everolimus—kidney cancer	0.00287	0.00287	CcSEcCtD
Lincomycin—Phlebitis—Capecitabine—kidney cancer	0.00285	0.00285	CcSEcCtD
Lincomycin—Pain—Pazopanib—kidney cancer	0.00284	0.00284	CcSEcCtD
Lincomycin—Thrombophlebitis—Capecitabine—kidney cancer	0.00283	0.00283	CcSEcCtD
Lincomycin—Stomatitis—Vincristine—kidney cancer	0.00283	0.00283	CcSEcCtD
Lincomycin—Hepatic function abnormal—Capecitabine—kidney cancer	0.00281	0.00281	CcSEcCtD
Lincomycin—Abdominal pain—Temsirolimus—kidney cancer	0.00278	0.00278	CcSEcCtD
Lincomycin—Body temperature increased—Temsirolimus—kidney cancer	0.00278	0.00278	CcSEcCtD
Lincomycin—Liver function test abnormal—Paclitaxel—kidney cancer	0.00276	0.00276	CcSEcCtD
Lincomycin—Erythema multiforme—Dactinomycin—kidney cancer	0.00276	0.00276	CcSEcCtD
Lincomycin—Abscess—Doxorubicin—kidney cancer	0.00275	0.00275	CcSEcCtD
Lincomycin—Rash pustular—Doxorubicin—kidney cancer	0.00273	0.00273	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.00273	0.00273	CcSEcCtD
Lincomycin—Stomatitis—Gemcitabine—kidney cancer	0.00268	0.00268	CcSEcCtD
Lincomycin—Abdominal pain—Pazopanib—kidney cancer	0.00262	0.00262	CcSEcCtD
Lincomycin—Hypersensitivity—Temsirolimus—kidney cancer	0.00259	0.00259	CcSEcCtD
Lincomycin—Shock—Everolimus—kidney cancer	0.00258	0.00258	CcSEcCtD
Lincomycin—Agranulocytosis—Gemcitabine—kidney cancer	0.00257	0.00257	CcSEcCtD
Lincomycin—Dermatitis bullous—Capecitabine—kidney cancer	0.00257	0.00257	CcSEcCtD
Lincomycin—Angioedema—Sorafenib—kidney cancer	0.00255	0.00255	CcSEcCtD
Lincomycin—Leukopenia—Sorafenib—kidney cancer	0.00249	0.00249	CcSEcCtD
Lincomycin—Pruritus—Temsirolimus—kidney cancer	0.00249	0.00249	CcSEcCtD
Lincomycin—Shock—Erlotinib—kidney cancer	0.00249	0.00249	CcSEcCtD
Lincomycin—Pancytopenia—Paclitaxel—kidney cancer	0.00245	0.00245	CcSEcCtD
Lincomycin—Angioedema—Sunitinib—kidney cancer	0.00245	0.00245	CcSEcCtD
Lincomycin—Hypotension—Everolimus—kidney cancer	0.00245	0.00245	CcSEcCtD
Lincomycin—Neutropenia—Paclitaxel—kidney cancer	0.00242	0.00242	CcSEcCtD
Lincomycin—Diarrhoea—Temsirolimus—kidney cancer	0.00241	0.00241	CcSEcCtD
Lincomycin—Leukopenia—Sunitinib—kidney cancer	0.0024	0.0024	CcSEcCtD
Lincomycin—Oliguria—Doxorubicin—kidney cancer	0.00236	0.00236	CcSEcCtD
Lincomycin—Glossitis—Doxorubicin—kidney cancer	0.00236	0.00236	CcSEcCtD
Lincomycin—Pruritus—Pazopanib—kidney cancer	0.00235	0.00235	CcSEcCtD
Lincomycin—Erythema multiforme—Gemcitabine—kidney cancer	0.00234	0.00234	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.00228	0.00228	CcSEcCtD
Lincomycin—Anaphylactic shock—Sorafenib—kidney cancer	0.00227	0.00227	CcSEcCtD
Lincomycin—Leukopenia—Dactinomycin—kidney cancer	0.00227	0.00227	CcSEcCtD
Lincomycin—Diarrhoea—Pazopanib—kidney cancer	0.00227	0.00227	CcSEcCtD
Lincomycin—Liver function test abnormal—Capecitabine—kidney cancer	0.00227	0.00227	CcSEcCtD
Lincomycin—Pain—Vinblastine—kidney cancer	0.00225	0.00225	CcSEcCtD
Lincomycin—Stomatitis—Paclitaxel—kidney cancer	0.00225	0.00225	CcSEcCtD
Lincomycin—Pain—Everolimus—kidney cancer	0.00224	0.00224	CcSEcCtD
Lincomycin—Vomiting—Temsirolimus—kidney cancer	0.00224	0.00224	CcSEcCtD
Lincomycin—Shock—Sorafenib—kidney cancer	0.00224	0.00224	CcSEcCtD
Lincomycin—Rash—Temsirolimus—kidney cancer	0.00222	0.00222	CcSEcCtD
Lincomycin—Dermatitis—Temsirolimus—kidney cancer	0.00222	0.00222	CcSEcCtD
Lincomycin—Vaginal inflammation—Doxorubicin—kidney cancer	0.00218	0.00218	CcSEcCtD
Lincomycin—Pain—Erlotinib—kidney cancer	0.00216	0.00216	CcSEcCtD
Lincomycin—Shock—Sunitinib—kidney cancer	0.00215	0.00215	CcSEcCtD
Lincomycin—Vomiting—Pazopanib—kidney cancer	0.00211	0.00211	CcSEcCtD
Lincomycin—Colitis—Doxorubicin—kidney cancer	0.00209	0.00209	CcSEcCtD
Lincomycin—Rash—Pazopanib—kidney cancer	0.00209	0.00209	CcSEcCtD
Lincomycin—Nausea—Temsirolimus—kidney cancer	0.00209	0.00209	CcSEcCtD
Lincomycin—Dermatitis—Pazopanib—kidney cancer	0.00209	0.00209	CcSEcCtD
Lincomycin—Abdominal pain—Vinblastine—kidney cancer	0.00208	0.00208	CcSEcCtD
Lincomycin—Abdominal pain—Everolimus—kidney cancer	0.00207	0.00207	CcSEcCtD
Lincomycin—Body temperature increased—Everolimus—kidney cancer	0.00207	0.00207	CcSEcCtD
Lincomycin—Vaginal infection—Doxorubicin—kidney cancer	0.00206	0.00206	CcSEcCtD
Lincomycin—Aplastic anaemia—Doxorubicin—kidney cancer	0.00205	0.00205	CcSEcCtD
Lincomycin—Vertigo—Vincristine—kidney cancer	0.00204	0.00204	CcSEcCtD
Lincomycin—Abdominal discomfort—Capecitabine—kidney cancer	0.00203	0.00203	CcSEcCtD
Lincomycin—Leukopenia—Vincristine—kidney cancer	0.00203	0.00203	CcSEcCtD
Lincomycin—Pancytopenia—Capecitabine—kidney cancer	0.00201	0.00201	CcSEcCtD
Lincomycin—Abdominal pain—Erlotinib—kidney cancer	0.002	0.002	CcSEcCtD
Lincomycin—Body temperature increased—Erlotinib—kidney cancer	0.002	0.002	CcSEcCtD
Lincomycin—Oesophagitis—Doxorubicin—kidney cancer	0.00199	0.00199	CcSEcCtD
Lincomycin—Neutropenia—Capecitabine—kidney cancer	0.00198	0.00198	CcSEcCtD
Lincomycin—Nausea—Pazopanib—kidney cancer	0.00197	0.00197	CcSEcCtD
Lincomycin—Erythema multiforme—Paclitaxel—kidney cancer	0.00196	0.00196	CcSEcCtD
Lincomycin—Pain—Sorafenib—kidney cancer	0.00194	0.00194	CcSEcCtD
Lincomycin—Hypersensitivity—Vinblastine—kidney cancer	0.00194	0.00194	CcSEcCtD
Lincomycin—Hypersensitivity—Everolimus—kidney cancer	0.00193	0.00193	CcSEcCtD
Lincomycin—Tinnitus—Paclitaxel—kidney cancer	0.00193	0.00193	CcSEcCtD
Lincomycin—Leukopenia—Gemcitabine—kidney cancer	0.00193	0.00193	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.00187	0.00187	CcSEcCtD
Lincomycin—Pain—Sunitinib—kidney cancer	0.00187	0.00187	CcSEcCtD
Lincomycin—Pruritus—Everolimus—kidney cancer	0.00185	0.00185	CcSEcCtD
Lincomycin—Anaphylactic shock—Vincristine—kidney cancer	0.00185	0.00185	CcSEcCtD
Lincomycin—Stomatitis—Capecitabine—kidney cancer	0.00184	0.00184	CcSEcCtD
Lincomycin—Jaundice—Capecitabine—kidney cancer	0.00184	0.00184	CcSEcCtD
Lincomycin—Phlebitis—Doxorubicin—kidney cancer	0.00184	0.00184	CcSEcCtD
Lincomycin—Thrombophlebitis—Doxorubicin—kidney cancer	0.00183	0.00183	CcSEcCtD
Lincomycin—Hepatic function abnormal—Doxorubicin—kidney cancer	0.00181	0.00181	CcSEcCtD
Lincomycin—Urticaria—Sorafenib—kidney cancer	0.00181	0.00181	CcSEcCtD
Lincomycin—Diarrhoea—Vinblastine—kidney cancer	0.0018	0.0018	CcSEcCtD
Lincomycin—Abdominal pain—Sorafenib—kidney cancer	0.0018	0.0018	CcSEcCtD
Lincomycin—Body temperature increased—Sorafenib—kidney cancer	0.0018	0.0018	CcSEcCtD
Lincomycin—Diarrhoea—Everolimus—kidney cancer	0.00179	0.00179	CcSEcCtD
Lincomycin—Pruritus—Erlotinib—kidney cancer	0.00179	0.00179	CcSEcCtD
Lincomycin—Pain—Dactinomycin—kidney cancer	0.00177	0.00177	CcSEcCtD
Lincomycin—Agranulocytosis—Capecitabine—kidney cancer	0.00176	0.00176	CcSEcCtD
Lincomycin—Anaphylactic shock—Gemcitabine—kidney cancer	0.00176	0.00176	CcSEcCtD
Lincomycin—Body temperature increased—Sunitinib—kidney cancer	0.00173	0.00173	CcSEcCtD
Lincomycin—Abdominal pain—Sunitinib—kidney cancer	0.00173	0.00173	CcSEcCtD
Lincomycin—Diarrhoea—Erlotinib—kidney cancer	0.00173	0.00173	CcSEcCtD
Lincomycin—Hypotension—Vincristine—kidney cancer	0.00173	0.00173	CcSEcCtD
Lincomycin—Hypersensitivity—Sorafenib—kidney cancer	0.00167	0.00167	CcSEcCtD
Lincomycin—Vomiting—Vinblastine—kidney cancer	0.00167	0.00167	CcSEcCtD
Lincomycin—Vomiting—Everolimus—kidney cancer	0.00167	0.00167	CcSEcCtD
Lincomycin—Dermatitis bullous—Doxorubicin—kidney cancer	0.00165	0.00165	CcSEcCtD
Lincomycin—Rash—Everolimus—kidney cancer	0.00165	0.00165	CcSEcCtD
Lincomycin—Dermatitis—Everolimus—kidney cancer	0.00165	0.00165	CcSEcCtD
Lincomycin—Angioedema—Paclitaxel—kidney cancer	0.00165	0.00165	CcSEcCtD
Lincomycin—Hypotension—Gemcitabine—kidney cancer	0.00164	0.00164	CcSEcCtD
Lincomycin—Abdominal pain—Dactinomycin—kidney cancer	0.00164	0.00164	CcSEcCtD
Lincomycin—Body temperature increased—Dactinomycin—kidney cancer	0.00164	0.00164	CcSEcCtD
Lincomycin—Vertigo—Paclitaxel—kidney cancer	0.00162	0.00162	CcSEcCtD
Lincomycin—Leukopenia—Paclitaxel—kidney cancer	0.00161	0.00161	CcSEcCtD
Lincomycin—Hypersensitivity—Sunitinib—kidney cancer	0.00161	0.00161	CcSEcCtD
Lincomycin—Pruritus—Sorafenib—kidney cancer	0.00161	0.00161	CcSEcCtD
Lincomycin—Vomiting—Erlotinib—kidney cancer	0.00161	0.00161	CcSEcCtD
Lincomycin—Erythema multiforme—Capecitabine—kidney cancer	0.00161	0.00161	CcSEcCtD
Lincomycin—Rash—Erlotinib—kidney cancer	0.00159	0.00159	CcSEcCtD
Lincomycin—Dermatitis—Erlotinib—kidney cancer	0.00159	0.00159	CcSEcCtD
Lincomycin—Tinnitus—Capecitabine—kidney cancer	0.00158	0.00158	CcSEcCtD
Lincomycin—Pain—Vincristine—kidney cancer	0.00158	0.00158	CcSEcCtD
Lincomycin—Nausea—Vinblastine—kidney cancer	0.00156	0.00156	CcSEcCtD
Lincomycin—Nausea—Everolimus—kidney cancer	0.00156	0.00156	CcSEcCtD
Lincomycin—Diarrhoea—Sorafenib—kidney cancer	0.00156	0.00156	CcSEcCtD
Lincomycin—Pruritus—Sunitinib—kidney cancer	0.00155	0.00155	CcSEcCtD
Lincomycin—Hypersensitivity—Dactinomycin—kidney cancer	0.00153	0.00153	CcSEcCtD
Lincomycin—Pain—Gemcitabine—kidney cancer	0.0015	0.0015	CcSEcCtD
Lincomycin—Nausea—Erlotinib—kidney cancer	0.0015	0.0015	CcSEcCtD
Lincomycin—Diarrhoea—Sunitinib—kidney cancer	0.0015	0.0015	CcSEcCtD
Lincomycin—Anaphylactic shock—Paclitaxel—kidney cancer	0.00147	0.00147	CcSEcCtD
Lincomycin—Abdominal pain—Vincristine—kidney cancer	0.00146	0.00146	CcSEcCtD
Lincomycin—Body temperature increased—Vincristine—kidney cancer	0.00146	0.00146	CcSEcCtD
Lincomycin—Liver function test abnormal—Doxorubicin—kidney cancer	0.00146	0.00146	CcSEcCtD
Lincomycin—Shock—Paclitaxel—kidney cancer	0.00145	0.00145	CcSEcCtD
Lincomycin—Vomiting—Sorafenib—kidney cancer	0.00145	0.00145	CcSEcCtD
Lincomycin—Rash—Sorafenib—kidney cancer	0.00143	0.00143	CcSEcCtD
Lincomycin—Dermatitis—Sorafenib—kidney cancer	0.00143	0.00143	CcSEcCtD
Lincomycin—Diarrhoea—Dactinomycin—kidney cancer	0.00142	0.00142	CcSEcCtD
Lincomycin—Vomiting—Sunitinib—kidney cancer	0.00139	0.00139	CcSEcCtD
Lincomycin—Body temperature increased—Gemcitabine—kidney cancer	0.00139	0.00139	CcSEcCtD
Lincomycin—Rash—Sunitinib—kidney cancer	0.00138	0.00138	CcSEcCtD
Lincomycin—Dermatitis—Sunitinib—kidney cancer	0.00138	0.00138	CcSEcCtD
Lincomycin—Hypotension—Paclitaxel—kidney cancer	0.00137	0.00137	CcSEcCtD
Lincomycin—Hypersensitivity—Vincristine—kidney cancer	0.00136	0.00136	CcSEcCtD
Lincomycin—Nausea—Sorafenib—kidney cancer	0.00135	0.00135	CcSEcCtD
Lincomycin—Vertigo—Capecitabine—kidney cancer	0.00133	0.00133	CcSEcCtD
Lincomycin—Leukopenia—Capecitabine—kidney cancer	0.00132	0.00132	CcSEcCtD
Lincomycin—Vomiting—Dactinomycin—kidney cancer	0.00132	0.00132	CcSEcCtD
Lincomycin—Rash—Dactinomycin—kidney cancer	0.00131	0.00131	CcSEcCtD
Lincomycin—Nausea—Sunitinib—kidney cancer	0.0013	0.0013	CcSEcCtD
Lincomycin—Pancytopenia—Doxorubicin—kidney cancer	0.0013	0.0013	CcSEcCtD
Lincomycin—Neutropenia—Doxorubicin—kidney cancer	0.00128	0.00128	CcSEcCtD
Lincomycin—Diarrhoea—Vincristine—kidney cancer	0.00127	0.00127	CcSEcCtD
Lincomycin—Pain—Paclitaxel—kidney cancer	0.00126	0.00126	CcSEcCtD
Lincomycin—Pruritus—Gemcitabine—kidney cancer	0.00124	0.00124	CcSEcCtD
Lincomycin—Nausea—Dactinomycin—kidney cancer	0.00123	0.00123	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.00121	0.00121	CcSEcCtD
Lincomycin—Diarrhoea—Gemcitabine—kidney cancer	0.0012	0.0012	CcSEcCtD
Lincomycin—Jaundice—Doxorubicin—kidney cancer	0.00119	0.00119	CcSEcCtD
Lincomycin—Stomatitis—Doxorubicin—kidney cancer	0.00119	0.00119	CcSEcCtD
Lincomycin—Shock—Capecitabine—kidney cancer	0.00119	0.00119	CcSEcCtD
Lincomycin—Vomiting—Vincristine—kidney cancer	0.00118	0.00118	CcSEcCtD
Lincomycin—Urticaria—Paclitaxel—kidney cancer	0.00117	0.00117	CcSEcCtD
Lincomycin—Rash—Vincristine—kidney cancer	0.00117	0.00117	CcSEcCtD
Lincomycin—Dermatitis—Vincristine—kidney cancer	0.00117	0.00117	CcSEcCtD
Lincomycin—Abdominal pain—Paclitaxel—kidney cancer	0.00116	0.00116	CcSEcCtD
Lincomycin—Body temperature increased—Paclitaxel—kidney cancer	0.00116	0.00116	CcSEcCtD
Lincomycin—Agranulocytosis—Doxorubicin—kidney cancer	0.00114	0.00114	CcSEcCtD
Lincomycin—Hypotension—Capecitabine—kidney cancer	0.00113	0.00113	CcSEcCtD
Lincomycin—Vomiting—Gemcitabine—kidney cancer	0.00112	0.00112	CcSEcCtD
Lincomycin—Rash—Gemcitabine—kidney cancer	0.00111	0.00111	CcSEcCtD
Lincomycin—Dermatitis—Gemcitabine—kidney cancer	0.00111	0.00111	CcSEcCtD
Lincomycin—Nausea—Vincristine—kidney cancer	0.0011	0.0011	CcSEcCtD
Lincomycin—Hypersensitivity—Paclitaxel—kidney cancer	0.00108	0.00108	CcSEcCtD
Lincomycin—Nausea—Gemcitabine—kidney cancer	0.00104	0.00104	CcSEcCtD
Lincomycin—Pruritus—Paclitaxel—kidney cancer	0.00104	0.00104	CcSEcCtD
Lincomycin—Erythema multiforme—Doxorubicin—kidney cancer	0.00103	0.00103	CcSEcCtD
Lincomycin—Pain—Capecitabine—kidney cancer	0.00103	0.00103	CcSEcCtD
Lincomycin—Tinnitus—Doxorubicin—kidney cancer	0.00102	0.00102	CcSEcCtD
Lincomycin—Diarrhoea—Paclitaxel—kidney cancer	0.00101	0.00101	CcSEcCtD
Lincomycin—Urticaria—Capecitabine—kidney cancer	0.000958	0.000958	CcSEcCtD
Lincomycin—Abdominal pain—Capecitabine—kidney cancer	0.000953	0.000953	CcSEcCtD
Lincomycin—Body temperature increased—Capecitabine—kidney cancer	0.000953	0.000953	CcSEcCtD
Lincomycin—Vomiting—Paclitaxel—kidney cancer	0.000934	0.000934	CcSEcCtD
Lincomycin—Rash—Paclitaxel—kidney cancer	0.000927	0.000927	CcSEcCtD
Lincomycin—Dermatitis—Paclitaxel—kidney cancer	0.000926	0.000926	CcSEcCtD
Lincomycin—Hypersensitivity—Capecitabine—kidney cancer	0.000889	0.000889	CcSEcCtD
Lincomycin—Nausea—Paclitaxel—kidney cancer	0.000873	0.000873	CcSEcCtD
Lincomycin—Vertigo—Doxorubicin—kidney cancer	0.000856	0.000856	CcSEcCtD
Lincomycin—Pruritus—Capecitabine—kidney cancer	0.000853	0.000853	CcSEcCtD
Lincomycin—Leukopenia—Doxorubicin—kidney cancer	0.000853	0.000853	CcSEcCtD
Lincomycin—Diarrhoea—Capecitabine—kidney cancer	0.000825	0.000825	CcSEcCtD
Lincomycin—Anaphylactic shock—Doxorubicin—kidney cancer	0.000777	0.000777	CcSEcCtD
Lincomycin—Vomiting—Capecitabine—kidney cancer	0.000767	0.000767	CcSEcCtD
Lincomycin—Shock—Doxorubicin—kidney cancer	0.000765	0.000765	CcSEcCtD
Lincomycin—Rash—Capecitabine—kidney cancer	0.00076	0.00076	CcSEcCtD
Lincomycin—Dermatitis—Capecitabine—kidney cancer	0.00076	0.00076	CcSEcCtD
Lincomycin—Hypotension—Doxorubicin—kidney cancer	0.000726	0.000726	CcSEcCtD
Lincomycin—Nausea—Capecitabine—kidney cancer	0.000716	0.000716	CcSEcCtD
Lincomycin—Pain—Doxorubicin—kidney cancer	0.000665	0.000665	CcSEcCtD
Lincomycin—Urticaria—Doxorubicin—kidney cancer	0.000618	0.000618	CcSEcCtD
Lincomycin—Abdominal pain—Doxorubicin—kidney cancer	0.000615	0.000615	CcSEcCtD
Lincomycin—Body temperature increased—Doxorubicin—kidney cancer	0.000615	0.000615	CcSEcCtD
Lincomycin—Hypersensitivity—Doxorubicin—kidney cancer	0.000573	0.000573	CcSEcCtD
Lincomycin—Pruritus—Doxorubicin—kidney cancer	0.00055	0.00055	CcSEcCtD
Lincomycin—Diarrhoea—Doxorubicin—kidney cancer	0.000532	0.000532	CcSEcCtD
Lincomycin—Vomiting—Doxorubicin—kidney cancer	0.000494	0.000494	CcSEcCtD
Lincomycin—Rash—Doxorubicin—kidney cancer	0.00049	0.00049	CcSEcCtD
Lincomycin—Dermatitis—Doxorubicin—kidney cancer	0.00049	0.00049	CcSEcCtD
Lincomycin—Nausea—Doxorubicin—kidney cancer	0.000462	0.000462	CcSEcCtD
